Summary
The prevalence of anti-C100-3 increases with age from 0.41% to 1.26%. It is more frequent in donors with elevated ALT (4.5%). Most ALT elevations, however, are not related to anti-C100-3. Low EIA signals (<3 x cutoff) are often non-specific. The cutofï value should be 2.5 times higher. High EIA signals correlate with ALT elevations.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Weiner AJ, Truett MA, Rosenblatt J, Han J, Quan S, Polito AJ, Kuo G, Choo Q-L, Houghton M, Agius C, Page E, Nelles MJ (1990) HCV testing in low-risk population. Lancet 336: 695
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag
About this paper
Cite this paper
Caspari, G., Beyer, HJ., Gerlich, W.H., Schmitt, H. (1992). Assay of antibodies to hepatitis C virus protein C100-3 in blood donors from Northern Germany. In: De Bac, C., Taliani, G., Gerlich, W.H. (eds) Chronically Evolving Viral Hepatitis. Archives of Virology, vol 4. Springer, Vienna. https://doi.org/10.1007/978-3-7091-5633-9_56
Download citation
DOI: https://doi.org/10.1007/978-3-7091-5633-9_56
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82350-7
Online ISBN: 978-3-7091-5633-9
eBook Packages: Springer Book Archive